"McClary, Dan Otho (May 1952). "Factors Affecting the Morphology of Candida Albicans". Annals of the Missouri Botanical Garden39 (2): 137–164. JSTOR2394509. doi:10.2307/2394509.
Zadik Yehuda, Burnstein Saar, Derazne Estella, Sandler Vadim, Ianculovici Clariel, Halperin Tamar (March 2010). "Colonization of Candida: prevalence among tongue-pierced and non-pierced immunocompetent adults". Oral Dis16 (2): 172–5. PMID19732353. doi:10.1111/j.1601-0825.2009.01618.x.
Santos, MA; Cheesman, C; Costa, V; Moradas-Ferreira, P; Tuite, MF (February 1999). "Selective advantages created by codon ambiguity allowed for the evolution of an alternative genetic code in Candida spp.". Molecular Microbiology31 (3): 937–947. PMID10048036. doi:10.1046/j.1365-2958.1999.01233.x.
Berman J, Sudbery PE (2002). "Candida Albicans: a molecular revolution built on lessons from budding yeast". Nature Reviews Genetics3 (12): 918–930. PMID12459722. doi:10.1038/nrg948.
Staab, J. F. (1999). "Adhesive and Mammalian Transglutaminase Substrate Properties of Candida albicans Hwp1". Science283 (5407): 1535–1538. ISSN0036-8075. doi:10.1126/science.283.5407.1535.
Di Giacomo, Raffaele; Maresca, Bruno; Porta, Amalia; Sabatino, Paolo; Carapella, Giovanni; Neitzert, Heinz-Christoph (2013). "Candida albicans/MWCNTs: A Stable Conductive Bio-Nanocomposite and Its Temperature-Sensing Properties". IEEE Transactions on Nanotechnology12 (2): 111. doi:10.1109/TNANO.2013.2239308.
Rambach, G; Oberhauser, H; Speth, C; Lass-Flörl, C (2011). "Susceptibility of Candida species and various moulds to antimycotic drugs: Use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey". Medical mycology : official publication of the International Society for Human and Animal Mycology49 (8): 856–63. PMID21619497. doi:10.3109/13693786.2011.583943.
"McClary, Dan Otho (May 1952). "Factors Affecting the Morphology of Candida Albicans". Annals of the Missouri Botanical Garden39 (2): 137–164. JSTOR2394509. doi:10.2307/2394509.
Andrzej (Anjay) Elzanowski and Jim Ostell (7 July 2010). "The Alternative Yeast Nuclear Code". The Genetic Codes. Bethesda, Maryland, U.S.A.: National Center for Biotechnology Information (NCBI). Consultado o 30 October 2011.
Santos, MA; Cheesman, C; Costa, V; Moradas-Ferreira, P; Tuite, MF (February 1999). "Selective advantages created by codon ambiguity allowed for the evolution of an alternative genetic code in Candida spp.". Molecular Microbiology31 (3): 937–947. PMID10048036. doi:10.1046/j.1365-2958.1999.01233.x.
Berman J, Sudbery PE (2002). "Candida Albicans: a molecular revolution built on lessons from budding yeast". Nature Reviews Genetics3 (12): 918–930. PMID12459722. doi:10.1038/nrg948.
Rambach, G; Oberhauser, H; Speth, C; Lass-Flörl, C (2011). "Susceptibility of Candida species and various moulds to antimycotic drugs: Use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey". Medical mycology : official publication of the International Society for Human and Animal Mycology49 (8): 856–63. PMID21619497. doi:10.3109/13693786.2011.583943.
Staab, J. F. (1999). "Adhesive and Mammalian Transglutaminase Substrate Properties of Candida albicans Hwp1". Science283 (5407): 1535–1538. ISSN0036-8075. doi:10.1126/science.283.5407.1535.